Drugs News and Research RSS Feed - Drugs News and Research

First Edition: August 29, 2014

First Edition: August 29, 2014

Today's early morning highlights from the major news organizations, including reports about the Obama administration and Pennsylvania reaching an agreement to expand Medicaid in that state. [More]
International consortium to accelerate collaborative multi-site trials of potential Ebola vaccine

International consortium to accelerate collaborative multi-site trials of potential Ebola vaccine

A candidate Ebola vaccine could be given to healthy volunteers in the UK, The Gambia and Mali as early as September, as part of an series of safety trials of potential vaccines aimed at preventing the disease that has killed more than 1,400 people in the current outbreak in West Africa. [More]
Minnesota researchers develop animal research model for FSHD

Minnesota researchers develop animal research model for FSHD

Researchers at the University of Minnesota have developed an animal research model for facioscapulohumeral muscular dystrophy (FSHD) to be used for muscle regeneration research as well as studies of the effectiveness of potential therapies for FSHD. [More]
TGen to lead first-in-patient clinical trial studies to test novel drugs for glioblastoma

TGen to lead first-in-patient clinical trial studies to test novel drugs for glioblastoma

SIn 2012, The Ben & Catherine Ivy Foundation awarded $10 million in grants for two groundbreaking brain cancer research projects at the Translational Genomics Research Institute. One of those projects has officially received the final regulatory approval from University of California, San Francisco, which means patient enrollment for the trial can begin. [More]
State highlights: Heroin deaths rise in N.Y.; TennCare computer system delay; Colo. races to win $87M to integrate care;

State highlights: Heroin deaths rise in N.Y.; TennCare computer system delay; Colo. races to win $87M to integrate care;

A heroin crisis gripping communities across the country deepened in New York last year, with more people in the city dying in overdoses from the drug than in any year since 2003. In all, 420 people fatally overdosed on heroin in 2013 out of a total of 782 drug overdoses, rising to a level not seen in a decade in both absolute numbers and as a population-adjusted rate, according to preliminary year-end data from the city's health department (Goodman, 8/28). [More]
Longer looks: A new kind of abortion war; foster kids and psychotropic drugs

Longer looks: A new kind of abortion war; foster kids and psychotropic drugs

While pro-life activists fight to rescue IVF embryos from the freezer, pregnant women in their third trimester with catastrophic fetal anomalies have nowhere to turn. ... Perhaps there is no other issue that touches on so many core dimensions of American society-;legal, medical, scientific, theological, political, philosophical, biological, ethical, and ecological. What some on one side of the debate call reproductive justice, others call taking a life. What some call a person, others call a cluster of cells. [More]
Colorectal cancer therapies market to remain constant at $7.7 billion by 2023

Colorectal cancer therapies market to remain constant at $7.7 billion by 2023

Decision Resources Group finds that the market for colorectal cancer (CRC) therapies will remain constant, at around $7.7 billion by 2023 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan. [More]
Risk-based treatment approach should be considered for patients with hypertension

Risk-based treatment approach should be considered for patients with hypertension

Blood pressure-lowering treatment should target patients at greatest cardiovascular risk and not just those with the highest baseline levels, suggest findings of a meta-analysis. [More]
Many people with severe rheumatoid arthritis failing to take expensive medication

Many people with severe rheumatoid arthritis failing to take expensive medication

Large numbers of people with severe rheumatoid arthritis are failing to take expensive medication as prescribed, according to a new multi-centre study led by researchers in Manchester. [More]
Isis Pharmaceuticals begins ISIS-APOCIIIRx Phase 3 study in FCS patients

Isis Pharmaceuticals begins ISIS-APOCIIIRx Phase 3 study in FCS patients

Isis Pharmaceuticals, Inc. announced the initiation of a Phase 3 study evaluating ISIS-APOCIIIRx in patients with familial chylomicronemia syndrome (FCS). FCS is a rare orphan disease, characterized by extremely high triglyceride levels, that affects an estimated 3,000 to 5,000 patients worldwide. [More]
New Coalition helps prevent abuse, misuse, diversion of ADHD drug

New Coalition helps prevent abuse, misuse, diversion of ADHD drug

Today is the official launch of a newly formed Coalition of medical, mental health, higher education, student and pharmaceutical organizations that will work together to help prevent misuse, abuse and diversion of ADHD prescription stimulant medication. The Coalition will initially focus its efforts on college students. [More]
First Edition: August 28, 2014

First Edition: August 28, 2014

Today's headlines include reports about the Congressional Budget Office's latest projections regarding Medicare and Medicaid spending. [More]
Scientists alter emotional associations of specific memories

Scientists alter emotional associations of specific memories

By manipulating neural circuits in the brain of mice, scientists have altered the emotional associations of specific memories. [More]
Study: Many HIV infected African-Americans may not be receiving effective doses of maraviroc drug

Study: Many HIV infected African-Americans may not be receiving effective doses of maraviroc drug

Many African-Americans may not be getting effective doses of the HIV drug maraviroc, a new study from Johns Hopkins suggests. The initial dosing studies, completed before the drug was licensed in 2007, included mostly European-Americans, who generally lack a protein that is key to removing maraviroc from the body. [More]

Gang involvement poses serious health-related risks for African American girls

Being involved in a gang poses considerable health-related risks for adolescent African American girls, including more casual sex partners and substance abuse combined with less testing for HIV and less knowledge about preventing sexually transmitted diseases, according to a new study. [More]
New evidence puts into doubt the long-held depression belief

New evidence puts into doubt the long-held depression belief

New evidence puts into doubt the long-standing belief that a deficiency in serotonin - a chemical messenger in the brain - plays a central role in depression. In the journal ACS Chemical Neuroscience, scientists report that mice lacking the ability to make serotonin in their brains (and thus should have been "depressed" by conventional wisdom) did not show depression-like symptoms. [More]

Nepstar's Q2 2014 revenue increases by 7.5% to RMB686.6 million (US$110.7 million)

China Nepstar Chain Drugstore Ltd., a leading retail drugstore chain in China based on the number of directly operated stores, today announced its unaudited financial results for the second quarter ended June 30, 2014. [More]
Receiving prescription at discharge improves outcomes in stroke patients

Receiving prescription at discharge improves outcomes in stroke patients

Stroke patients are 70 per cent more likely to continue taking their stroke prevention medications one year later if they have a prescription in hand when discharged - according to researchers at St. Michael's Hospital and the Institute for Clinical Evaluative Sciences. [More]
THC may slow or halt progression of Alzheimer's disease

THC may slow or halt progression of Alzheimer's disease

Extremely low levels of the compound in marijuana known as delta-9-tetrahydrocannabinol, or THC, may slow or halt the progression of Alzheimer's disease, a recent study from neuroscientists at the University of South Florida shows. [More]
Amgen's ivabradine receives FDA priority review designation for treatment of chronic heart failure

Amgen's ivabradine receives FDA priority review designation for treatment of chronic heart failure

Amgen today announced the U.S. Food and Drug Administration has granted priority review designation for ivabradine for the treatment of chronic heart failure (HF). [More]